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ABSTRACT 25 
2-Aryl isatogens and their 3-imino derivatives have been extensively studied but to date there 26 
have been no reported variants carrying pyrrolyl substituents at the 2-position. This study describes the 27 
unexpected synthesis of two novel 3-imino-2-(pyrrol-2-yl) isatogen derivatives upon attempted amide 28 
couplings with (E)- or (Z)-3-(3,5-dimethyl-1H-pyrrol-2-yl)-2-(2-nitrophenyl)acrylic acids and p-29 
phenylenediamines in the presence of uronium-based coupling reagents. Imine hydrolysis of one 30 
derivative under mild acid conditions afforded a 2-pyrrolyl isatogen in high yield. The compound 31 
showed potent in vitro antiplasmodial activity against Plasmodium falciparum.32 
3 
 
Introduction 33 
2-Substituted-3-H-indol-3-one-N-oxides (isatogens) are a well-known class of compounds that 34 
possess, for example, antiplasmodial, antifungal and antibacterial activities, with active derivatives 35 
carrying a variety of alkyl and (hetero)aryl groups at C2 and substituents on the 6-membered ring (e.g. 36 
1 and 2, Figure 1).[1-4] The broad antimicrobial properties of the class have been attributed to redox 37 
processes within cells and the N-oxide reduction potential.[1,2] Some isatogens are useful as spin traps 38 
for detecting short lived radicals in electron paramagnetic spectroscopy and as quenchers in radical 39 
polymerisation chemistry.[5,6] Strategies for the synthesis of isatogens include metal-catalysed 40 
cyclisation of 2-nitrophenylacetylides[2,4,5] and oxidation of 2-nitrophenylalkenes to diketones, followed 41 
by nitro reduction and cyclisation.[2,6] 42 
 43 
The closely related 3-imino isatogens are another well-studied class that, among other 44 
applications, can be useful as synthetic intermediates.  For example, 3-phenylimino-2-phenyl isatogen 45 
3 undergoes 1,3-dipolar cycloadditions with electron deficient alkenes to provide isoxazolidine 46 
derivatives.[7] Synthesis of 3-arylimino isatogens can be achieved via reaction of 2-substituted indole-47 
N-oxides with nitrosoarenes.[8,9] While there is a rich literature surrounding isatogens and their 3-imino 48 
derivatives, there are no reported examples from either class containing pyrrolyl substituents at C2. 49 
This paper reports the unexpected synthesis of two novel 3-arylimino -2-(pyrrol-2-yl) isatogens and a 50 
facile hydrolytic cleavage that provided a 2-pyrrolyl isatogen. 51 
 52 
Results and Discussion 53 
In 2013 we reported the synthesis and preliminary evaluation of (E)- and (Z)-3,5-dimethyl-1H-54 
pyrrol-2-yl-2-arylacrylate esters and amides 4 (Scheme 1) as a new class of angiogenesis inhibitors 55 
related to sunitinib (Sutent®).[10] At the outset of this previous study, we envisaged that esters/amides 4 56 
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should be accessible from the corresponding acids (E)-5 and (Z)-5, respectively, using standard 57 
ester/amide coupling chemistry. However, attempts to couple these acids (both isomers) with a variety 58 
of alcohols and amines resulted in pyrrole N-acylation/cyclisation to the 5,7-dimethyl-2-aryl-3H-59 
pyrrolizin-3-one 6 (Scheme 1(a)). An alternative route to the target esters and amides was eventually 60 
identified using a novel adaptation of the Knoevenagel reaction, where pre-formed 2-(2-nitrophenyl) 61 
esters/amides are reacted with an N-methylcarbamoyl pyrrole-2-carbaldehyde.[10] We also recently 62 
reported a divergent one-pot synthesis of substituted 5,7-dimethyl-2-aryl-3H-pyrrolizin-3-ones and 63 
showed that these too, constitute a new class of angiogenesis inhibitors.[11] 64 
 65 
Acids (E)-5 and (Z)-5 were obtained for the current work in identical yields (84%) from the 66 
reported allyl esters (Z)-7 and (E)-7[10] via Pd-catalysed deallylation in the presence of morpholine 67 
(Scheme 1(a)). Crystals of (Z)-5 suitable for X-ray analysis were obtained from Et2O/pet spirit and its 68 
structure was determined. The X-ray data confirmed the structure of (Z)-5 while also revealing the 69 
presence of an intramolecular hydrogen bond between the pyrrole NH and carbonyl oxygen atoms 70 
(NH---O distance 1.9 Å), which served to stabilise the molecule into a pseudo-7-membered ring 71 
conformation (Scheme 1(b)). Evidence that the H-bond was retained in solution was found in the 72 
compound’s 1H NMR spectrum (CDCl3), where the pyrrole NH signal for (Z)-5 appeared far downfield 73 
at 11.87 ppm (c.f. 6.78 ppm for (E)-5). The equivalent H-bond was observed previously in the allyl 74 
ester (Z)-7.[10] 75 
 76 
While studying amidation reactions of 5 it was noted that attempted amide coupling of (E)-5 77 
and N,N-dimethyl-p-phenylenediamine (DMPD) 8 in CH2Cl2 using 1-[bis(dimethylamino)methylene]-78 
1H-1,2,3-triazolo[4,5-b]pyridinium-3-oxide hexafluorophosphate (HATU) in the absence of tertiary 79 
amine base resulted in very different reactivity. Rather than forming the amide or the dark red 80 
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pyrrolizin-3-one 6, a deep purple solid was obtained as the major product. Proving difficult to 81 
characterise by spectroscopic methods, a crystal of the compound was grown from Et2O/pet spirit and 82 
its X-ray structure determined. The compound was revealed to be the novel 3-imino 2-(2-pyrrolyl) 83 
isatogen 10, containing an intramolecular H-bond between the pyrrole NH and N-oxide oxygen atoms 84 
(NH---O distance 1.9 Å) that stabilised the molecule into a pseudo-6-membered ring conformation 85 
(Scheme 2(a)). The H-bond was also evident in CDCl3 solution, as indicated by the far downfield 86 
chemical shift of the pyrrole NH signal (11.86 ppm) in the 1H NMR spectrum of 10. With the structure 87 
of 10 confirmed, the yield of the reaction was calculated at 40%. Similar yields were obtained with the 88 
cis-acid (Z)-5 and when the coupling reagent was switched to 2-(1H-benzotriazol-1-yl)-1,1,3,3-89 
tetramethyluronium hexafluorophosphate (HBTU). 90 
 91 
Reaction of (Z)-5 with p-phenylenediamine (PPD) 9 under the same conditions using HATU 92 
gave the analogous 3-imino-2-(pyrrol-2-yl) isatogen 11 in 56% yield. Compound 11 was found to be 93 
unstable, however, degrading over the course of days in air at ambient temperature to mixtures that 94 
contained, among other compounds, the 2-(pyrrol-2-yl) isatogen 12 and PPD, suggesting hydrolytic 95 
lability of the imine bond. Treatment of freshly prepared 11 with 1 M HCl(aq):THF (1:1) at room 96 
temperature for 30 min was subsequently found to deliver 12 in quantitative yield. A crystal of 12 was 97 
obtained from Et2O/pet spirit and its structure confirmed by X-ray analysis (Scheme 2(b)). As with 10, 98 
the X-ray structure of 12 revealed an intramolecular H-bond between the pyrrole NH and N-oxide 99 
oxygen atoms (NH---O distance 2.2 Å), consistent with the downfield chemical shift (11.64 ppm) 100 
observed for the pyrrole NH signal in its 1H NMR spectrum (CDCl3). 101 
 102 
Isatogen 12 was tested using the microdilution radioisotope technique for antiplasmodial 103 
activity against the K1 (multidrug resistant) strain of Plasmodium falciparum at the National Centre for 104 
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Genetic Engineering and Biotechnology (BIOTEC) Thailand, where it returned an IC50 = 381 nM.
[12] 105 
Cytotoxicity of 12 in Vero cells was measured using the Alamar blue viability assay[13] at CC50 = 58.4 106 
µM (selectivity index = 153). The activity/selectivity of 12 was consistent with previous values for 107 
closely related 2-aryl isatogens (e.g. compound 2, IC50 = 227 nM FcB1 strain, CC50 = 31 µM MCF7 108 
cells, selectivity index = 136).[2]  109 
 110 
In summary, 2-(2-nitrophenyl) acrylates (E)-5 and (Z)-5, prepared in high yield from the 111 
reported allyl esters (E)-7 and (Z)-7, were found to undergo unprecedented reactions with p-112 
phenylenediamines and HATU/HBTU in CH2Cl2 to form novel 3-imino-2-(pyrrol-2-yl) isatogen 113 
derivatives 10 and 11 in moderate yields. Whilst not speculated on here, the mechanism of this 114 
intriguing transformation warrants further investigation. Compound 11 could be rapidly and 115 
quantitatively hydrolysed under mild, acidic conditions to the parent ketone 12 – the first reported 2-116 
pyrrolyl isatogen. Compound 12 showed potent in vitro antiplasmodial activity and low eukaryotic cell 117 
toxicity, in line with literature data for structurally similar 2-aryl isatogens. 118 
 119 
Experimental – Sample Procedure 120 
(E)-2-(3,5-dimethyl-1H-pyrrol-2-yl)-3-((4(dimethylamino)phenyl)imino)-3H-indole-1-oxide (10) 121 
 HATU (372 mg, 0.98 mmol) was added to a stirring solution of (E)-5 (201 mg, 0.70 mmol) in CH2Cl2 122 
(10 mL) and the mixture stirred at room temperature for 5 minutes, before adding N,N-dimethyl-p-123 
phenylenediamine 8 (95.3 mg, 0.70 mmol) in one portion. The reaction was stirred at room temperature 124 
and monitored by TLC analysis (3:7 EtOAc:pet spirit). After 3 h the mixture was extracted with EtOAc 125 
(3 x 25 mL) and the combined organic phase washed with brine (2 x 25 mL), dried over anhydrous 126 
MgSO4 and concentrated. The crude residue was purified by silica gel column chromatography using a 127 
gradient from 100% pet spirit to 8:2 pet spirit:EtOAc to give 3-imino isatogen 10 (100 mg, 40%) as a 128 
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deep purple solid. Use of the same procedure with (Z)-7 or with HBTU resulted in similar yields of 10. 129 
M.P. 146-148 °C. 1H NMR (CDCl3, 500 MHz): δ 2.33 (s, 3H), 2.51 (s, 3H), 3.04 (s, 6H), 5.96 (d, 1H, J 130 
= 2.1 Hz), 6.80 (d, 2H, J = 8.5 Hz), 7.05 (d, 2H, J = 9.0 Hz), 7.07 (t, 1H, J = 7.5 Hz), 7.12 (d, 1H, J = 131 
7.5 Hz), 7.44 (t, 1H, J = 7.5 Hz), 7.63 (d, 1H, J = 7.5 Hz), 11.86 (br s, 1H, NH). 13C NMR (CDCl3, 126 132 
MHz): δ 13.6, 16.7, 40.9, 106.6 112.8, 113.1, 113.9, 117.3, 119.0, 121.7, 123.8, 127.9, 128.8, 132.0, 133 
132.6, 139.5, 148.1, 149.3, 154.8. HRMS-ESI: m/z calcd for C22H23N4O [M+H]
+ 359.1866; observed 134 
359.1868. FTIR: neat (cm-1) 2920, 2340, 1730, 1595, 1521, 1448, 1350, 1277, 1205, 1185, 1117. 135 
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Figures and Schemes 177 
 178 
Figure 1. Structures of representative isatogens and 3-phenylimino-2-phenyl isatogen. 179 
 180 
 181 
 182 
 183 
 184 
 185 
 186 
 187 
 188 
 189 
 190 
Scheme 1. (a) Synthesis of acids (E)-5 and (Z)-5. Reagents and conditions: a. Pd(PPh3)4 (10 mol%), 191 
morpholine, THF, rt, 2 h; (E)-5 84% from (E)-7, (Z)-5 84% from (Z)-7. (b) X-ray crystal structure of 192 
(Z)-5. Anisotropic displacement ellipsoids represent 30% probability levels. Hydrogen atoms are drawn 193 
as circles with small radii. (CCDC accession number: (Z)-5 490884). 194 
 195 
 196 
 197 
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 201 
 202 
 203 
 204 
 205 
 206 
 207 
Scheme 2. (a) Synthesis of 3-imino-2-(pyrrol-2-yl) isatogens 10 and 11 from (E)-5 or (Z)-5. (b) Acid 208 
hydrolysis of 11 afforded the 2-(pyrrol-2-yl) isatogen 12 in quantitative yield. X-ray structures of 10 209 
and 12 are shown at right. Anisotropic displacement ellipsoids represent 30% probability levels. 210 
Hydrogen atoms are drawn as circles with small radii. (CCDC accession numbers: 10 1490885, 12 211 
1490886). 212 
 213 
 214 
